CHARLOTTE, N.C.--(BUSINESS WIRE)--The Premier healthcare alliance has awarded new agreements for drug eluting coronary stents, non-drug eluting coronary stents and diagnostic and interventional cardiology products.
Suppliers being awarded for drug eluting coronary stents, non-drug eluting coronary stents and diagnostic and interventional cardiology products include: Abbott Laboratories Inc., Abbott Vascular Division of Alpharetta, Ga.; Boston Scientific Company of Natick, Mass.; and Medtronic Inc., of Minneapolis.
Suppliers being awarded for diagnostic and interventional cardiology products include: Arrow International Inc., of Reading Penn.; Johnson & Johnson Health Care Systems Inc. of Piscataway, N.J.; Merit Medical Systems Inc., of South Jordan, Utah; Oscor Inc., of Palm Harbor, Fla.; and St. Jude Medical of Saint Paul, Minn.
Effective July 1, 2013, the agreements are available to acute care and continuum of care members of Premier. Johnson & Johnson is available to acute care and surgery center members of Premier.
About the Premier healthcare alliance, Malcolm Baldrige National Quality Award recipient
Premier is one of the nation’s largest performance improvement alliances of approximately 2,900 U.S. community hospitals and 100,000 alternate sites using the power of collaboration and technology to lead the transformation to coordinated, high-quality, cost-effective care. Owned by healthcare providers, Premier operates a leading purchasing network that provided members more than $5 billion in savings in FY2012. Premier also maintains clinical, financial and outcomes databases based on 1 in every 4 U.S. patient discharges. A world leader in measurably improving patient care, Premier has one of the largest performance improvement collaboratives in America, including one in partnership with the Centers for Medicare & Medicaid Services. Headquartered in Charlotte, N.C., Premier also has an office in Washington. https://www.premierinc.com.
